Amplitude vs. Agilysys: What Do the Revenue Trends for These Tech Companies Tell Investors?

Amplitude and Agilysys both delivered quarter-over-quarter revenue growth over the last eight periods, but Amplitude’s sales stayed higher ($93.5M in Q1 2026 vs. $82.9M for Agilysys). The quality of growth diverged: Amplitude’s net loss widened to -$23.3M and free cash flow swung to -$13.2M, attributed to higher costs from an AI push, while Agilysys remained profitable (net income $12.3M) with record Q4 free cash flow of $35.4M and 12% y/y revenue growth. Overall, the article frames Amplitude as faster-growing but less financially resilient, with investors urged to monitor whether the revenue gap widens or converges.

Analysis

This is a quality-vs-size setup, not a pure top-line race. AGYS screens better because the market usually pays a premium for visible cash conversion in vertical software, while AMPL’s AI spend and legal overhang create a higher probability of multiple compression if growth does not translate into operating leverage within the next 1-2 quarters. In other words, the gap that matters is not revenue dollars; it is whether incremental revenue is being converted into durable free cash flow.

Second-order, AGYS has a cleaner reinvestment story: hospitality software is a sticky workflow layer, so even modest growth with expanding margins can justify a rerating if retention stays high. AMPL’s AI assistant could be strategically real, but the market is unlikely to underwrite a long-duration platform multiple while cash burn remains negative and litigation risk is unresolved. That makes AMPL more vulnerable to “show-me” selling on any guidance miss or slower AI monetization.

Contrarian take: the consensus may be over-indexing on AMPL’s current revenue run-rate and underweighting the possibility that AI features widen the product moat over 6-18 months. If next earnings show improving net retention and a clear path back to positive FCF, the stock could rebound sharply because expectations are already cautious. The thesis breaks if AGYS growth slows below low-teens or if AMPL posts another quarter of negative FCF without a measurable gross margin or bookings inflection.

Key Decisions for Investors

• Long AGYS / short AMPL as a quality-vs-growth pair trade over the next 1-2 earnings cycles; thesis is that AGYS deserves a premium for FCF and margin durability while AMPL’s reinvestment story remains unproven. Stop if AMPL prints two consecutive quarters of improving FCF and gross margin expansion.
• If initiating fresh exposure, prefer buying AGYS on any post-earnings pullback rather than chasing strength; the risk/reward is better because downside is supported by profitability while upside comes from continued multiple expansion if revenue stays in the low-teens.
• Avoid outright shorting AMPL into the next print; if bearish, use a put spread or defined-risk downside structure because small-cap SaaS names with AI narratives can squeeze on incremental product news. Reassess if guidance implies FCF breakeven within 2 quarters.
• Watch for any legal or regulatory update on AMPL as a catalyst for valuation compression; a material escalation would be a cleaner short trigger than the revenue gap itself. A resolution without financial impact would remove an overhang and weaken the short case.
• Use IGV as a sector sanity check: if software multiples are expanding broadly, relative underperformance in AMPL should be interpreted as company-specific, not macro-driven, and that favors staying with the AGYS/AMPL pair rather than a beta bet.